AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — Board/Management Information 2021
Feb 3, 2021
61842_rns_2021-02-03_f2b3fdb1-a295-4e87-9f24-0710c56eb50d.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Communication Address: Solara Active Pharma Sciences Limited Batra Centre
No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
February 3, 2021
The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051
Scrip Code: 541540
Scrip Code: SOLARA
Dear Sirs,
Sub: Appointment of Mr. Subash Anand as Executive Director and CFO
The Board at its meeting held today (February 3, 2021), appointed Mr. Subash Anand (DIN: 07348933) as Executive Director and CFO of the Company with effect from April 01, 2021.
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015 is enclosed.
We request you to take the same on record.
Thanking you, Yours faithfully,
For Solara Active Pharma Sciences Limited
==> picture [146 x 39] intentionally omitted <==
S. Murali Krishna Company Secretary
Encl: Disclosure.
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Communication Address: Solara Active Pharma Sciences Limited Batra Centre
No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : [email protected] www.solara.co.in
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Appointment of Mr. Subash Anand as Executive Director and Chief Financial Officer (ED & CFO)
| No. | Particulars | Remarks | Remarks | |
|---|---|---|---|---|
| 1. | Reason for change viz., appointment or otherwise |
Mr. Subash Anand appointed as ED & CFO | ||
| 2. | Date of Appointment | August 19,2020 | ||
| 3. | Effective date of appointment as ED & CFO |
April 01, 2021 | ||
| 4. | Brief Profile | Subhash is a qualified AICWA (India) & Certified Management Accountant (CMA) from the Institute of Management Accountants (USA) with 30+ years of manaerial and rofessional exerience with |
||
| g p p |
||||
| Multinational and Indian companies. His last held position was as President & CFO at PI Industries Ltd (PIIL). Prior to PIIL, he worked in Whirlpool, Sterlite Industries, Hindustan Copper Ltd and Calcom in senior finance roles. |
||||
| 5. | Disclosure of relationship between directors |
Mr. Subash Anand, is not related to any promoter, director or keymanagerialpersonnel of the company. |
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942